Abstract
SARS-CoV-2 (CoV-2) is mainly transmitted in the human population during close contact and respiratory droplets. It is currently unclear, however, whether CoV-2 is shed into milk and may also be transmitted from infected mothers to newborns trough breast feeding. Two recent reviews on the topic (1,2) did not find evidence for CoV-2 in human milk. However, the number of breast milk samples analyzed so far is small and samples were taken only once from each mother (2).
It is currently unclear whether SARS-CoV-2 (CoV-2) may be shed into breast milk and transmitted through breastfeeding. Recent reviews and research articles reported no evidence for CoV-2 in human breast milk but the sample size was small.1–3
Here, we examined milk samples from two CoV-2 infected nursing mothers (M1 and M2). An overview on the clinical data and time course of infection is provided in Fig. 1A. We determined CoV-2 viral loads using RT-qPCR for CoV-2 N and -ORF1b4 (Fig. S1) in whole milk and skim milk obtained after removal of the lipid fraction. All four milk samples obtained from M1 from day 12 to 14 tested negative (Fig. 1B). In contrast, CoV-2 RNA was detected in milk provided by M2 on days 10 (left and right breast), 12, 13 and 14, while a later sample from day 25 was negative (Fig. 1A). Peak levels were detected on day 12 with Ct values for CoV-2 N of 29.8 and 30.4 in whole milk and skim milk, respectively (Fig. 1B, top), corresponding to viral genome copy numbers of 1.32 × 105 and 9.48 × 104 per ml (mean of both isolations, Fig. 1B, bottom). Since milk components may affect RNA isolation and quantification, viral RNA recovery rates upon spiking milk with serial dilutions of a CoV-2 stock were determined. We observed an up to 89.2% reduced recovery rate in whole milk and 51.5% in skim milk (Fig. S2) suggesting that the actual viral loads in whole milk of M2 may be even higher (Fig. 1C).
We detected CoV-2 RNA in milk samples collected over a period of 4 days. Based on specimen handling, internal controls, and negative testing of M1 milk, contamination can be excluded. Detection of viral RNA in milk of M2 coincided with mild COVID-19 symptoms and a CoV-2 positive diagnostic testing of the newborn (N2) (Fig. 1A). M2 was wearing a surgical mask since the onset of symptoms and followed safety precautions during handling or feeding the neonate, including proper hand and breast disinfection, strict washing and sterilization of milk pumps and tubes. However, whether N2 was infected by breastfeeding or other modes of transmission remains unclear. Further studies of milk samples from lactating women and possible virus transmission via breastfeeding are needed to develop recommendations on whether mothers with COVID-19 should breastfeed.
Data Availability
All primary data will be made available to qualified individuals upon request.
Authors’ Contributions
R.G., C.C. and J.A.M. contributed equally to this study. R.G. performed RNA extraction, RT-qPCR analysis and evaluated data. C.C. and J.A.M. generated virus stock handled milk samples and prepared them for RNA extraction. S.S. supervised BSL3 work and helped in writing. K.S. organized samples and was involved in study design. F.K. and J.M. supervised the project and wrote the article.
Ethics statement
Both mothers were informed about the study and gave informed consent. Ethical approval for this study was waived by the Ethics Committee of Ulm University because this study is case report and all samples were anonymized.